Description: This tablet combines cefpodoxime proxetil, a cephalosporin antibiotic, with potassium clavulanate, a beta-lactamase inhibitor. This combination broadens the spectrum of activity, making it effective against a wider range of bacterial infections. Cefpodoxime proxetil targets bacterial cell wall synthesis, while potassium clavulanate helps overcome bacterial resistance by inhibiting enzymes that would otherwise inactivate the antibiotic. It is prescribed for various infections, including respiratory tract infections, skin infections, and urinary tract infections.